Zakas, Philip M http://orcid.org/0000-0002-4919-5182
Brown, Harrison C
Knight, Kristopher
Meeks, Shannon L http://orcid.org/0000-0002-3683-8644
Spencer, H Trent
Gaucher, Eric A
Doering, Christopher B
Article History
Received: 1 February 2016
Accepted: 22 August 2016
First Online: 26 September 2016
Competing interests
: C.B.D., E.A.G., H.T.S. and P.M.Z. are inventors on a patent application describing ancestral FVIII technology filed by Emory University/Children's Healthcare of Atlanta and the Georgia Institute of Technology. C.B.D. and H.T.S. are co-founders of Expression Therapeutics, LLC, and own equity in the company. Expression Therapeutics owns the intellectual property associated with ET3 and has plans to commercially develop technology used in the research described in this paper. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies.